Seroprevalencija i faktori rizika za infekciju virusom hepatitisa C u ...

80. Weber F. Interaction of hepatitis c virus with the type I interferon system.
World J Gastroenterol 2007; 13(36):4818-23.
81. Semmo N, Klenerman P. CD4+ T cell responses in hepatitis C infection.
World J Gastroenterol 2007; 13: 4831-8.
82. Neumann-Haefelin C, Spangenberg HC, Blum HE, Thimme R. Host and
viral factors contributing to CD8+ T cell failure in hepatitis C virus infection.
World J Gastroenterol 2007; 13:4839-47.
83. Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL, Ray SC.
Comprehensive analyses of CD8+ T cell responses during longitudinal
study of acute human hepatitis C. Hepatology 2005; 42:104-12.
84. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat
Immunol 2005; 6:353-60.
85. Mills KH. Regulatory T cells: friend or for in immunity to infection? Nat Rev
Immunol 2004; 4:841-55.
86. Suvas S, Rouse BT. Treg control of antimicrobial T cell responses. Curr
Opin Immunol 2006; 18:344-8.
87. Billerbeck E, Bottler T, Thimme R. Regulatory T cells in viral hepatitis.
World J Gastroenterol 2007; 13:4858-64.
88. Li S, Gowans EJ, Chougnet C, Plebanski M, Dittmer U. Natural regulatory T
cells and persistent viral infection. J Virol 2008; 82:21-30.
89. Zeisel MB, Fafi-Kremer S, Fofana I, et al. Neutralizing antibodies in
hepatitis C virus infection. World J Gastroenterol 2007; 13:4824-30.
90. Ferrari C, Urbani S, Penna A, et al. Immunopathogenesis of hepatitis C
virus infection. J Hepatol 1999; 31:31-8.
91. Mihaljević I. Serologic diagnosis of viral hepatitis A-E. Biochemia Med 2000:
10:161-73.
110